•  
  •  
  •  
  •  

2026-03-24 22:33:45

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • BEL and RRP Group sign strategic MoU to advance collaboration in Semiconductor, Unmanned Systems and Electro-Optics
  • United Spirits Ltd divests its stake in Royal Challengers Sports Pvt Ltd for INR 166.6 bn
  • ACME Solar Holdings Ltd arm commissions 2nd phase of BESS project
  • IKS Health and Certilytics Expand Strategic Collaboration to Bridge the Payer-Provider Gap with Agentic AI and Human-in-the-Loop Oversight
  • Triton Valves Ltd fixes Apr 1, 2026 as record date for 3:1 bonus issue

Keywords Selected:  Injection

Stock Report

  • Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • NATCO Pharma Launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price Starting from MRP INR 1,290
  • Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
  • Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India
  • Glenmark Pharmaceuticals Inc., USA to launch Potassium Phosphates Injections
  • Caplin Steriles gets USFDA approval for Potassium Phosphates Injection
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
  • Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial
  • Caplin Steriles gets USFDA approval for Linezolid Injection, Infusion bags
  • Caplin Steriles granted final approval by USFDA for Acetaminophen Injection, infusion bags
  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
  • Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP
  • Lupin Launches Liraglutide Injection in the United States
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial

Latest Post

  • BEL and RRP Group sign strategic MoU to advance collaboration in Semiconductor, Unmanned Systems and Electro-Optics
  • United Spirits Ltd divests its stake in Royal Challengers Sports Pvt Ltd for INR 166.6 bn
  • ACME Solar Holdings Ltd arm commissions 2nd phase of BESS project
  • IKS Health and Certilytics Expand Strategic Collaboration to Bridge the Payer-Provider Gap with Agentic AI and Human-in-the-Loop Oversight
  • Triton Valves Ltd fixes Apr 1, 2026 as record date for 3:1 bonus issue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025